Medicare Enrolled
Dr. Alexander Trujillo, MD
Cardiovascular Disease · Tomball, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Trujillo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Trujillo? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Trujillo
Dr. Alexander Trujillo is a cardiovascular disease in Tomball, TX, with 17 years in practice. Based on federal Medicare data, Dr. Trujillo performed 3,075 Medicare services across 1,856 unique beneficiaries.
Between the years covered by Open Payments, Dr. Trujillo received a total of $14,099 from 49 pharmaceutical and/or device companies across 404 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Trujillo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice▲ Top 34% volume in TX$ $14,099 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,075
Medicare services
Top 34% in TX for cardiovascular disease
1,856
Unique beneficiaries
$149
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~181 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 561 | $95 | $405 |
| Hospital follow-up visit, moderate complexity | 416 | $65 | $220 |
| Regadenoson injection (Lexiscan) for heart stress test | 364 | $45 | $170 |
| Electrocardiogram (EKG), 12-lead | 284 | $11 | $50 |
| Echocardiogram, transthoracic | 105 | $146 | $1,300 |
| Ultrasound of both sides of head and neck blood flow | 101 | $117 | $630 |
| Ultrasound of leg arteries or artery grafts | 101 | $194 | $798 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 97 | $33 | $120 |
| Initial hospital admission, moderate complexity | 96 | $106 | $420 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 93 | $57 | $210 |
| Hospital follow-up visit, high complexity | 90 | $95 | $320 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 87 | $605 | $805 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 85 | $1,969 | $6,890 |
| Remote patient monitoring management, 20 min/month | 81 | $40 | $150 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 80 | $10 | $40 |
| EKG interpretation and report | 72 | $7 | $27 |
| Cardiac catheterization | 41 | $161 | $915 |
| Remote patient monitoring device, 30 days | 38 | $41 | $150 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 37 | $16 | $55 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 30 | $20 | $80 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 30 | $682 | $2,215 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 28 | $136 | $620 |
| New patient office visit (45-59 min) | 28 | $134 | $525 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 27 | $75 | $295 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, each additional vessel | 25 | $62 | $245 |
| Coronary stent placement | 24 | $455 | $1,825 |
| Insertion of tube into intracranial artery for diagnosis or treatment with review by radiologist | 21 | $393 | $990 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 11 | $62 | $240 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $17 | $70 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $11 | $45 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.5% high complexity
27.9% medium
66.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,099
Total received (2018-2024)
Avg $2,014/year across 7 years
Top 25% in TX for cardiovascular disease
49
Companies
404
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,954 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$145 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,572
2023$1,586
2022$1,004
2021$1,213
2020$906
2019$6,567
2018$1,252
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic Vascular, Inc.
$5,897
Abbott Laboratories
$929
Janssen Pharmaceuticals, Inc
$798
Medtronic, Inc.
$725
Boston Scientific Corporation
$601
AstraZeneca Pharmaceuticals LP
$599
Bard Peripheral Vascular, Inc.
$439
Novartis Pharmaceuticals Corporation
$417
Amgen Inc.
$366
Merck Sharp & Dohme LLC
$354
Boehringer Ingelheim Pharmaceuticals, Inc.
$311
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$276
ABIOMED
$233
Actelion Pharmaceuticals US, Inc.
$209
PFIZER INC.
$199
Cook Medical LLC
$185
Impulse Dynamics (USA) Inc.
$178
Esperion Therapeutics, Inc.
$168
E.R. Squibb & Sons, L.L.C.
$139
HEARTFLOW, INC.
$121
Lexicon Pharmaceuticals, Inc.
$106
Baxter Healthcare
$75
Tactile Systems Technology Inc
$69
BOSTON SCIENTIFIC CORPORATION
$64
Merck Sharp & Dohme Corporation
$56
Kowa Pharmaceuticals America, Inc.
$49
Astellas Pharma US Inc
$43
Biosense Webster, Inc.
$38
Chiesi USA, Inc.
$38
Edwards Lifesciences Corporation
$35
ARBOR PHARMACEUTICALS, INC.
$33
BARD PERIPHERAL VASCULAR, INC.
$30
KCI USA, Inc.
$27
Alnylam Pharmaceuticals Inc.
$27
Kestra Medical Technology Services, Inc.
$24
Novo Nordisk Inc
$23
SANOFI-AVENTIS U.S. LLC
$23
BIOTRONIK INC.
$22
AngioDynamics, Inc.
$21
Cardiovascular Systems Inc.
$19
Amarin Pharma Inc.
$17
Bard Access Systems, Inc.
$17
Amicus Therapeutics, Inc.
$16
Stryker Corporation
$16
Arbor Pharmaceuticals, Inc.
$15
CashFlow Solutions, LLC
$14
Arrow International, Inc.
$14
InfoBionic, Inc
$11
Allergan Inc.
$11
Top 3 companies account for 54.1% of total payments
Associated products mentioned in payments ›
ACCOLADE · ACTIV.A.C. · Assure WCD · Azure · BRILINTA · BYSTOLIC · CAMZYOS · CARDENE · CARDIOMEMS · CARTO 3 · COBALT DR MRI SURESCAN · CONFIRM RX · COOK MEDICAL ZILVER PTX · Claria MRI · Confirm Rx · Connectivity and Remote care · Corlanor · ELIQUIS · ENDURANT IIS · ENTRESTO · EUPHORA · Edarbi · Euphora · FARXIGA · FFRct · FLEXITOUCH · Flexitouch Plus · GENERAL THERAPIES · GENERAL - VASCULAR INTERVENTION · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · Hillrom - Carnation Ambulatory Monitor · INVOKANA · Impella · Inpefa · JARDIANCE · KENGREAL · LEQVIO · LEXISCAN · LIFESTENT · LIFESTREAM · LINQ II · LUTONIX · LUX-DX · LYMPHA PRESS OPTIMAL PLUS(US) BT · LifeVest · Livalo · Merlin Connectivity and Remote · Micra · Mitra Clip system · MitraClip System · MoMe Kardia · N/A · NEXLETOL · NEXLIZET · ONPATTRO · ONYX FRONTIER · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · Ozempic · PRADAXA · PRALUENT · PROGEL · Quartet CRT Lead · RESOLUTE ONYX · Repatha · Resolute · Reveal LINQ · Rotablator Rotational Atherectomy System Console Kit · Rotarex · SAPIEN 3 Ultra RESILIA · SYNERGY · TELESCOPE · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · Telescope · ULTRASCORE · UPTRAVI · VENASEAL · VENOVO · VERQUVO · VYNDAQEL · Varithena Administration Pack · Vascepa · Vein Treatment - Other Products · WATCHMAN Access System · WATCHMAN FLX · XARELTO · XIENCE SKYPOINT · ZILVER PTX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $458 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
170
Per 100K population
3.6
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE TOMBALL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Trujillo is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Trujillo experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Trujillo performed 561 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Trujillo receive payments from pharmaceutical companies?
Yes. Dr. Trujillo received a total of $14,099 from 49 companies across 404 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Trujillo's costs compare to other cardiovascular diseases in Tomball?
Dr. Trujillo's average Medicare payment per service is $149. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Trujillo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Tomball
Browse cardiovascular diseases in Tomball ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology